Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Department of Neurology, Cardiovascular Research Institute Maastricht, Maastricht University Medical Center, Maastricht, The Netherlands.
Eur Stroke J. 2023 Mar;8(1):215-223. doi: 10.1177/23969873221143210. Epub 2022 Dec 14.
Endovascular thrombectomy (EVT) increases the chance of good functional outcome after ischemic stroke caused by a large vessel occlusion, but the risk of death in the first 90 days is still considerable. We assessed the causes, timing and risk factors of death after EVT to aid future studies aiming to reduce mortality.
We used data from the MR CLEAN Registry, a prospective, multicenter, observational cohort study of patients treated with EVT in the Netherlands between March 2014, and November 2017. We assessed causes and timing of death and risk factors for death in the first 90 days after treatment. Causes and timing of death were determined by reviewing serious adverse event forms, discharge letters, or other written clinical information. Risk factors for death were determined with multivariable logistic regression.
Of 3180 patients treated with EVT, 863 (27.1%) died in the first 90 days. The most common causes of death were pneumonia (215 patients, 26.2%), intracranial hemorrhage (142 patients, 17.3%), withdrawal of life-sustaining treatment because of the initial stroke (110 patients, 13.4%) and space-occupying edema (101 patients, 12.3%). In total, 448 patients (52% of all deaths) died in the first week, with intracranial hemorrhage as most frequent cause. The strongest risk factors for death were hyperglycemia and functional dependency before the stroke and severe neurological deficit at 24-48 h after treatment.
When EVT fails to decrease the initial neurological deficit, strategies to prevent complications like pneumonia and intracranial hemorrhage after EVT could improve survival, as these are often the cause of death.
血管内血栓切除术(EVT)增加了因大血管闭塞引起的缺血性卒中后获得良好功能结局的机会,但在治疗后 90 天内的死亡风险仍然相当高。我们评估了 EVT 后死亡的原因、时间和危险因素,以帮助未来的研究旨在降低死亡率。
我们使用了来自 MR CLEAN 登记处的数据,该登记处是一项在荷兰进行的、前瞻性的、多中心、观察性队列研究,研究对象为 2014 年 3 月至 2017 年 11 月期间接受 EVT 治疗的患者。我们评估了治疗后 90 天内死亡的原因和时间以及死亡的 90 天内的危险因素。死亡的原因和时间是通过审查严重不良事件表、出院信或其他书面临床信息来确定的。死亡的危险因素是通过多变量逻辑回归来确定的。
在接受 EVT 治疗的 3180 名患者中,有 863 名(27.1%)在治疗后的 90 天内死亡。死亡的最常见原因是肺炎(215 例,26.2%)、颅内出血(142 例,17.3%)、因初始卒中而停止维持生命的治疗(110 例,13.4%)和占位性水肿(101 例,12.3%)。总共 448 例患者(所有死亡病例的 52%)在第一周内死亡,颅内出血是最常见的原因。死亡的最强危险因素是卒中前的高血糖和功能依赖性以及治疗后 24-48 小时的严重神经功能缺损。
当 EVT 未能降低初始神经功能缺损时,预防 EVT 后并发症(如肺炎和颅内出血)的策略可能会改善生存,因为这些通常是死亡的原因。